Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Dirschka

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Italian Journal of Dermatology and Venereology|March 27, 2026
A deep learning model for histopathological diagnosis of actinic keratosis: a diagnostic case control accuracy studyJulius Balkenhol, Max Schmidt, Tim Schnauder, et al.
Acta Dermato-Venereologica|May 25, 2017
A Novel Actinic Keratosis Field Assessment Scale for Grading Actinic Keratosis Disease SeverityBrigitte Dréno, Rino Cerio, Thomas Dirschka, et al.
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology|May 26, 2011
Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison studyBerthold Rzany, Christiane Bayerl, Isaac Bodokh, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 3, 2010
Perioral dermatitisAndreas Wollenberg, Thomas Bieber, Thomas Dirschka, et al.
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology|October 13, 2012
A randomised, double-blind comparison of 20 units of onabotulinumtoxinA with 30 units of incobotulinumtoxinA for glabellar linesMarion Moers-Carpi, Thomas Dirschka, Gabrielle Feller-Heppt, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 22, 2005
The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapiesSiegfried Segaert, Josep Tabernero, Olivier Chosidow, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 28, 2015
Daylight PDT with MAL - current data and practical recommendations of an expert panelWolfgang G Philipp-Dormston, Sigrid Karrer, Holger Petering, et al.
Acta Dermato-Venereologica|June 8, 2023
Expert Recommendations on Facilitating Personalized Approaches to Long-term Management of Actinic Keratosis: The Personalizing Actinic Keratosis Treatment (PAKT) ProjectColin Morton, Samira Baharlou, Nicole Basset-Seguin, et al.
Journal of the American Academy of Dermatology|June 1, 2019
A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosaceaMartin Schaller, Lajos Kemény, Blanka Havlickova, et al.
Dermatology and Therapy|December 12, 2025
Exploring New Dimensions in Longitudinal Rosacea ManagementMartin Schaller, Belinda Welsh, Giuseppe Micali, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Italian Journal of Dermatology and Venereology|March 27, 2026
A deep learning model for histopathological diagnosis of actinic keratosis: a diagnostic case control accuracy studyJulius Balkenhol, Max Schmidt, Tim Schnauder, et al.
Acta Dermato-Venereologica|May 25, 2017
A Novel Actinic Keratosis Field Assessment Scale for Grading Actinic Keratosis Disease SeverityBrigitte Dréno, Rino Cerio, Thomas Dirschka, et al.
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology|May 26, 2011
Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison studyBerthold Rzany, Christiane Bayerl, Isaac Bodokh, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 3, 2010
Perioral dermatitisAndreas Wollenberg, Thomas Bieber, Thomas Dirschka, et al.
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology|October 13, 2012
A randomised, double-blind comparison of 20 units of onabotulinumtoxinA with 30 units of incobotulinumtoxinA for glabellar linesMarion Moers-Carpi, Thomas Dirschka, Gabrielle Feller-Heppt, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 22, 2005
The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapiesSiegfried Segaert, Josep Tabernero, Olivier Chosidow, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 28, 2015
Daylight PDT with MAL - current data and practical recommendations of an expert panelWolfgang G Philipp-Dormston, Sigrid Karrer, Holger Petering, et al.
Acta Dermato-Venereologica|June 8, 2023
Expert Recommendations on Facilitating Personalized Approaches to Long-term Management of Actinic Keratosis: The Personalizing Actinic Keratosis Treatment (PAKT) ProjectColin Morton, Samira Baharlou, Nicole Basset-Seguin, et al.
Journal of the American Academy of Dermatology|June 1, 2019
A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosaceaMartin Schaller, Lajos Kemény, Blanka Havlickova, et al.
Dermatology and Therapy|December 12, 2025
Exploring New Dimensions in Longitudinal Rosacea ManagementMartin Schaller, Belinda Welsh, Giuseppe Micali, et al.
Pageof 11